Ann: Change in substantial holding, page-2

Perennial in their "Perennial Value Smaller Companies Trust" report for October indicated the following:

MedAdvisor (down 44.7%) likewise poorly communicated a slowerquarter with revenue up 3.5% but gross profit down 2.5%. With nogeneral call for investors, they jumped to negative conclusions andoverlooked clear positives such as an increase in cash to $12.3m andstill high gross margins of 84.7% in the strategically valuableAustralian business. We have engaged with the company to betterarticulate the strategic value in the business and if we see furtherprogress on this front, we will continue to add back to the positionhaving sold a large portion at 50c only months ago compared to themonth end price of 24c.

On that last part, it does seem like they paused buying between 31Oct & 14Nov and then have started up again.....14Nov being the day the company announced they were evaluating strategic options. As stated on that day, I'm just not sure the focus on share price achieves.....certainly clearer communication regarding plans, targets, performance all is beneficial, but someone digging around trying to find a buyer/s does what??